3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold

被引:25
作者
Abbasi, Maryam [1 ]
Sadeghi-Aliabadi, Hojjat [1 ]
Amanlou, Massoud [2 ]
机构
[1] Isfahan Univ Med Sci, Dept Med Chem, Fac Pharm, Esfahan 8174673461, Iran
[2] Univ Tehran Med Sci, Dept Med Chem, Drug Design & Dev Res Ctr, Fac Pharm, Tehran, Iran
关键词
Hsp90; isoxazole; 3D-QSAR; CoMFA; CoMSIA; molecular dynamic simulations; SIMILARITY INDEXES; ANALYSIS COMSIA; CHAPERONE; PHARMACOPHORE;
D O I
10.1080/07391102.2017.1326319
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock protein 90(Hsp90), as a molecular chaperone, play a crucial role in folding and proper function of many proteins. Hsp90 inhibitors containing isoxazole scaffold are currently being used in the treatment of cancer as tumor suppressers. Here in the present studies, new compounds based on isoxazole scaffold were predicted using a combination of molecular modeling techniques including three-dimensional quantitative structure-activity relationship (3D-QSAR), molecular docking and molecular dynamic (MD) simulations. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were also done. The steric and electrostatic contour map of CoMFA and CoMSIA were created. Hydrophobic, hydrogen bond donor and acceptor of CoMSIA model also were generated, and new compounds were predicted by CoMFA and CoMSIA contour maps. To investigate the binding modes of the predicted compounds in the active site of Hsp90, a molecular docking simulation was carried out. MD simulations were also conducted to evaluate the obtained results on the best predicted compound and the best reported Hsp90 inhibitors in the 3D-QSAR model. Findings indicate that the predicted ligands were stable in the active site of Hsp90.
引用
收藏
页码:1463 / 1478
页数:16
相关论文
共 42 条
[1]   Prediction of dual agents as an activator of mutant p53 and inhibitor of Hsp90 by docking, molecular dynamic simulation and virtual screening [J].
Abbasi, Maryam ;
Sadeghi-Aliabadi, Hojjat ;
Hassanzadeh, Farshid ;
Amanlou, Massoud .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2015, 61 :186-195
[2]   A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold [J].
Abbasi, Maryam ;
Ramezani, Fatemeh ;
Elyasi, Maryam ;
Sadeghi-Aliabadi, Hojjat ;
Amanlou, Massoud .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 23
[3]   Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers [J].
Abraham, Mark James ;
Murtola, Teemu ;
Schulz, Roland ;
Páll, Szilárd ;
Smith, Jeremy C. ;
Hess, Berk ;
Lindah, Erik .
SoftwareX, 2015, 1-2 :19-25
[4]   Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design [J].
Athar, Mohd ;
Lone, Mohsin Yousuf ;
Khedkar, Vijay M. ;
Jha, Prakash Chandra .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (06) :1282-1297
[5]   Molecular modeling of Helicobacter pylori arginase and the inhibitor coordination interactions [J].
Azizian, Homa ;
Bahrami, Homayoon ;
Pasalar, Parvin ;
Amanlou, Massoud .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (07) :626-635
[6]   Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors [J].
Bargiotti, Alberto ;
Musso, Loana ;
Dallavalle, Sabrina ;
Merlini, Lucio ;
Gallo, Grazia ;
Ciacci, Andrea ;
Giannini, Giuseppe ;
Cabri, Walter ;
Penco, Sergio ;
Vesci, Loredana ;
Castorina, Massimo ;
Milazzo, Ferdinando Maria ;
Cervoni, Maria Luisa ;
Barbarino, Marcella ;
Pisano, Claudio ;
Giommarelli, Chiara ;
Zuco, Valentina ;
De Cesare, Michelandrea ;
Zunino, Franco .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 :64-75
[7]   4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]pyridines as a new class of cytotoxic Hsp90 inhibitors [J].
Baruchello, Riccardo ;
Simoni, Daniele ;
Marchetti, Paolo ;
Rondanin, Riccardo ;
Mangiola, Stefania ;
Costantini, Cristiana ;
Meli, Maria ;
Giannini, Giuseppe ;
Vesci, Loredana ;
Carollo, Valeria ;
Brunetti, Tiziana ;
Battistuzzi, Gianfranco ;
Tolomeo, Manlio ;
Cabri, Walter .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 :53-60
[8]   Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90 [J].
Baruchello, Riccardo ;
Simoni, Daniele ;
Grisolia, Giuseppina ;
Barbato, Giuseppina ;
Marchetti, Paolo ;
Rondanin, Riccardo ;
Mangiola, Stefania ;
Giannini, Giuseppe ;
Brunetti, Tiziana ;
Alloatti, Domenico ;
Gallo, Grazia ;
Ciacci, Andrea ;
Vesci, Loredana ;
Castorina, Massimo ;
Milazzo, Ferdinando M. ;
Cervoni, Maria L. ;
Guglielmi, Mario B. ;
Barbarino, Marcella ;
Fodera, Rosanna ;
Pisano, Claudio ;
Cabri, Walter .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (24) :8592-8604
[9]   3D QSAR investigations on antimalarial naphthylisoquinoline alkaloids by comparative molecular similarity indices analysis (CoMSIA), based on different alignment approaches [J].
Bringmann, G ;
Rummey, C .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (01) :304-316
[10]   N-Aryl-benzimidazolones as novel small molecule HSP90 inhibitors [J].
Bruncko, Milan ;
Tahir, Stephen K. ;
Song, Xiaohong ;
Chen, Jun ;
Ding, Hong ;
Huth, Jeffrey R. ;
Jin, Sha ;
Judge, Russell A. ;
Madar, David J. ;
Park, Chang H. ;
Park, Cheol-Min ;
Petros, Andrew M. ;
Tse, Christin ;
Rosenberg, Saul H. ;
Elmore, Steven W. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) :7503-7506